W-922

N/A

Report date: 2022/01/11 17:33:01
NME

Base Information

Drug NameW-922
Drug Alias NameW-922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsPI3-kinase class I inhibitors
TargetsSerine/threonine-protein kinase B-rafPI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXi'An Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesXi'An Jiaotong University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A